Percutaneous permeation modifiers: Enhancement versus retardation

Expert Opinion on Drug Delivery

Volumn 5, Issue 5, 2008, Pages 517-529

  Kaushik, Diksha ^a   Batheja, Priya ^a   Kilfoyle, Brian ^a   Rai, Vishwas ^a   Michniak Kohn, Bozena ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Enhancers; Penetration modifiers; Retardants; Stratum corneum

Indexed keywords

(3 DODECANOYLOXAZOLIDIN 2 ONE); (DODECYL 2 (N,N DIMETHYLAMINO)PROPIONATE; 2 PYRROLIDONE DERIVATIVE; ALCOHOL; AMIDE; AMPHOLYTE; BENZALKONIUM CHLORIDE; CETRIMIDE; DECYL METHYL SULFOXIDE; DIETHYLTOLUAMIDE; DIMETHYL N (2 METHOXYCARBONYLBENZENESULFONYL)IMINOSULFURANE; DIMETHYL SULFOXIDE; DODECYL SULFATE SODIUM; DODECYLDIMETHYLAMINOACETATE; DRUG ADDITIVE; FATTY ACID; FATTY ALCOHOL; HYDROCORTISONE; LAUROCAPRAM; MACROGOL 400; MEFENAMIC ACID; MELATONIN; METRONIDAZOLE; N 0915; PENETRATION ENHANCING AGENT; PROPYLENE GLYCOL; SULFOXIDE; SURFACTANT; TERPENE DERIVATIVE;

CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; DRUG CONFORMATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; HUMAN; HYDROGEN BOND; MOLECULAR SIZE; NONHUMAN; PHYSICAL CHEMISTRY; POLARIZATION; REVIEW; SKIN ABSORPTION; SKIN PENETRATION; SKIN STRUCTURE; SKIN SURFACE; SKIN TOXICITY; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, CUTANEOUS; ALGORITHMS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; HUMANS; HYDROGEN BONDING; PHARMACEUTICAL PREPARATIONS; SKIN ABSORPTION;

EID: 45849117650     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.5.5.517     Document Type: Review

References (69)

1. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004;56(5):581-7
2. Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 1993;90(22):10504-8
3. Park EJ, Werner J, Smith NB. Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer. Pharm Res 2007;24(7):1396-401
4. Maibach H, Smith EW. Percutaneous penetration enhancer. Boca Raton: CRC Press; 1995
5. Walters K. Penetration enhancers and their use in transdermal therapeutic systems. New York: Marcel Dekker, Inc.; 1989
6. Sinha VR, Kaur MP. Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 2000;26(11):1131-40
7. Nedberge D, Campell PS, Gale RM, Yum SI. Transdermal contraceptive formulations. US4816258; 1989
8. Osdol W, Crisologo NM, Yum SII. Formulations for the transdermal administration of fenoldopam. US6960353; 2005
9. Baker EL Jr, Warren M, Zack M, et al. Epidemic malathion poisoning in Pakistan malaria workers. Lancet 1978;1 (8054):31-4
10. Braue E, Doxzon BF, Lumpkin HL, et al. Military perspectives in chemical penetration retardation. In: Smith E, Maibach HI, editors, Percutaneous penetration enhancers. Boca Raton: CRC, Taylor and Francis; 2006. p. 385-97
11. Schlumpf M, Jarry H, Wuttke W, et al. Estrogenic activity and estrogen receptor beta binding of the UV filter 3-benzylidene camphor. Comparison with 4-methylbenzylidene camphor. Toxicology 2004;199(2-3):109-20
12. Briassoulis G, Narlioglou M, Hatzis T. Toxic encephalopathy associated with use of DEET insect repellents: a case analysis of its toxicity in children. Hum Exp Toxicol 2001;20(1):8-14
13. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm 1999;184(1):1-6
14. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56(5):603-18
15. Kanikkannan N, Singh M. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm 2002;248(1-2):219-28
16. Moffat V, Green RD, Hadgraft J, et al. Functional siloxanes as skin penetration enhancers. In: Proceedings 18th Controlled Rel Bioact Mat Meeting: 1991; Amsterdam, Netherlands; 1991. p. 536-7
17. Song Y, Xiao C, Mendelsohn R, et al. Investigation of iminosulfuranes as novel transdermal penetration enhancers: enhancement activity and cytotoxicity. Pharm Res 2005;22(11):1918-25
18. Allan G. Azone. In: Maibach H, Smith EW, editors. Percutaneous penetration enhancer. Boca Raton: CRC Press; 1995. p. 129-36
19. Wester RC, Melendres J, Sedik L, Maibach HI. Percutaneous absorption of azone following single and multiple doses to human volunteers. J Pharm Sci 1994;83(2):124-5
20. Wiechers JW, Drenth BF, Jonkman JH, de Zeeuw RA. Percutaneous absorption and elimination of the penetration enhancer Azone in humans. Pharm Res 1987;4(6):519-23
21. Wiechers JW, Drenth BF, Jonkman JH, de Zeeuw RA. Percutaneous absorption, metabolic profiling, and excretion of the penetration enhancer azone after multiple dosing of an azone-containing triamcinolone acetonide cream in humans. J Pharm Sci 1990;79(2):111-5
22. Barry B. Skin transport. In: Barry B, editor. Dermatological formulations. Volume 18. New York: Marcel Dekker; 1983. p. 95-126
23. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14(2):101-14
24. Hadgraft J. Skin deep. Eur J Pharm Biopharm 2004;58(2):291-9
25. Hadgraft J. Modulation of the barrier function of the skin. Skin Pharmacol Appl Skin Physiol 2001;14(Suppl 1):72-81
26. Wertz P. The nature of the epidermal barrier: biochemical aspects. Adv Drug Del Rev 1996;18(3):283-94
27. Hadgraft J, Guy RH. Feasibility assessment in topical and transdermal delivery: mathematical models and in vitro studies. In: Guy R, Hadgraft J, editors, Transdermal drug delivery. New York: Marcel Dekker, 2003. p. 1-23
28. Barry BW. Breaching the skin's barrier to drugs. Nat Biotechnol 2004;22(2):165-7
29. Kanikkannan N, Kandimalla K, Lamba SS, Singh M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 2000;7(6):593-608
30. Hadgraft J, Peck J, Williams DG, et al. Mechanisms of action of skin penetration enhancers/retarders: azone and analogues. Inter J Pharm 1996;141(1-2):17-25
31. Hoogstraate AJ, Verhoef J, Brussee J, et al. Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkylazacycloheptanones. Int J Pharm 1991;76(1-2):37-47
32. Lewis D, Hadgraft J. Mixed monolayers of dipalmitoylphosphatidylcholine with Azone or oleic acid at the air-water interface. Int J Pharm 1990;65(3):211-8
33. Brain K, Walters KA. Molecular modeling of skin permeation enhancement by chemical agents. New York: Marcel Dekker, 1993
34. Hadgraft J, Walters KA. Skin penetration enhancement. In: de Boer A, editor. Drug absorption enhancement, concepts, possibilities, limitations and trends. Volume 177-198. Switzerland: Harwood Academic Publishers; 1994
35. Kim N, El-Khalili M, Henary MM, et al. Percutaneous penetration enhancement activity of aromatic S, S-dimethyliminosulfuranes. Int J Pharm 1999;187(2):219-29
36. Michniak-Kohn BB. Percutaneous permeation modifiers: enhancement vs retardation. In: AAPS Annual Meeting and Exposition: 2007; San Diego, CA: AAPS; 2007
37. Kaushik D, Michniak-Kohn BB. Vehicle-enhancer and vehicle-retardant effects on percutaneous permeation of DEET. In: AAPS Annual Meeting and Exposition: 2007; San Diego, CA: AAPS; 2007
38. Potts RO, Guy, Richard H. Mechanisms of transdermal drug delivery, vol. 83. New York: Marcel Dekker, 1997
39. Touitou E, Meidan VM, Horwitz E. Methods for quantitative determination of drug localized in the skin. J Control Release 1998;56(1-3):7-21
40. Hammell DC, Stolarczyk EI, Klausner M, et al. Bioconversion of naltrexone and its 3-O-alkyl-ester prodrugs in a human skin equivalent. J Pharm Sci 2005;94(4):828-36
41. Valiveti S, Hammell DC, Paudel KS, et al. In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs. J Control Release 2005;102(2):509-20
42. Coomes MW, Norling AH, Pohl RJ, et al. Foreign compound metabolism by isolated skin cells from the hairless mouse. J Pharmacol Exp Ther 1983;225(3):770-7
43. Milewich L, Kaimal V, Shaw CB. Sontheimer: epidermal keratinocytes: a source of 5 alpha-dihydrotestosterone production in human skin. J Clin Endocrinol Metab 1986;62(4):739-46
44. Thiboutot D, Jabara S, McAllister JM, et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized Sebocyte Cell Line (SEB-1). J Invest Dermatol 2003;120:905-14
45. Cormier M, Ledger PW, Marry JP, Amkraut A. In vitro cutaneous biotransformation of propranolol. J Invest Dermatol 1991;97(3):447-53
46. Zhu Z, Hotchkiss SA, Boobis AR, Edwards RJ. Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes. Biochem Biophys Res Commun 2002;297(1):65-70
47. Qvist MHHU, Kreilgaard B, Madsen F, et al. Application of confocal laser scanning microsc in characterization of chemical enhancers in drug-in-adhesive transdermal patches. AAPS PharmSci 2002;4(1):1-8
48. Mendelsohn R, Flach CR, Moore DJ. Determination of molecular conformation and permeation in skin via IR spectroscopy, microscopy, and imaging. Biochim Biophys Acta 2006;1758(7):923-33
49. Plasencia I, Norlen L, Bagatolli LA. Direct visualization of lipid domains in human skin stratum corneum's lipid membranes: effect of pH and temperature. Biophys J 2007;93(9):3142-55
50. Wartewig S, Neubert RH. Pharmaceutical applications of Mid-IR and Raman spectroscopy. Adv Drug Deliv Rev 2005;57(8):1144-70
51. Takahashi K, Sakano H, Yoshida M, et al. Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin. J Control Release 2001;73(2-3):351-8
52. Buyuktimkin S, Buyuktimkin N, Rytting JH. Interaction of indomethacin with a new penetration enhancer, dodecyl 2-(NN-dimethylamino)propionate (DDAIP): its effect on transdermal delivery. Int J Pharm 1996;127(2):245-53
53. Pappinen S, Tikkinen S, Pasonen-Seppanen S, et al. Rat epidermal keratinocyte organotypic culture (ROC) compared to human cadaver skin: the effect of skin permeation enhancers. Eur J Pharm Sci 2007;30(3-4):240-50
54. Pelletier M. Analytical applications of Raman spectroscopy. Blackwell Publishing; 1999
55. Whitehead K, Karr N, Mitragotri S. Safe and effective permeation enhancers for oral drug delivery. Pharm Res 2007
56. Heard CM, Screen C. Probing the permeation enhancement of mefenamic acid by ethanol across full-thickness skin, heat-separated epidermal membrane and heat-separated dermal membrane. Int J Pharm 2008;349(1-2):323-5
57. Andega S, Kanikkannan N, Singh M. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J Control Release 2001;77(1-2):17-25
58. Babu RJ, Pandit JK. Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin. Drug Deliv 2005;12(3):165-9
59. Sarigullu Ozguney I, Yesim Karasulu H, Kantarci G, et al. Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS PharmSciTech 2006;7(4):88
60. Kandimalla K, Kanikkannan N, Andega S, Singh M. Effect of fatty acids on the permeation of melatonin across rat and pig skin in vitro and on the transepidermal water loss in rats in vivo. J Pharm Pharmacol 1999;51(7):783-90
61. Nokhodchi A, Shokri J, Dashbolaghi A, et al. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm 2003;250(2):359-69
62. Sarpotdar PP, Zatz JL. Percutaneous absorption enhancement by non-ionic surfactants. Drug Dev Ind Pharm 1986;12:1625-47
63. Godwin DA, Michniak BB. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev Ind Pharm 1999;25(8):905-15
64. Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration enhancers. Drug Discov Today 2007;12(23-24):1061-7
65. Valenta C, Dabic T. Effect of urea and pantothenol on the permeation of progesterone through excised rat skin from polymer matrix systems. Drug Dev Ind Pharm 2001;27(1):57-62
66. Fincher TK, Yoo SD, Player MR, et al. In vitro evaluation of a series of N-dodecanoyl-L-amino acid methyl esters as dermal penetration enhancers. J Pharm Sci 1996;85(9):920-3
67. Singh BN, Singh RB, Singh J. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm 2005;298(1):98-107
68. Godwin DA, Michniak BB, Player MR, Sowell JW Sr. Transdermal and dermal enhancing activity of pyrrolidinones in hairless mouse skin. Int J Pharm 1997;155:241-50
69. Buyuktimkin S, Buyuktimkin N, Rytting JH. Synthesis and enhancing effect of dodecyl 2-(N,N-dimethylamino) propionate on the transepidermal delivery of indomethacin, clonidine, and hydrocortisone. Pharm Res 1993;10(11):1632-7